These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28838174)

  • 41. The Need and Potential of Inactivated Poliovirus Vaccine.
    Garon J; Orenstein W; John TJ
    Indian Pediatr; 2016 Aug; 53 Suppl 1():S2-S6. PubMed ID: 27771632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reflections on Modeling Poliovirus Transmission and the Polio Eradication Endgame.
    Thompson KM; Kalkowska DA
    Risk Anal; 2021 Feb; 41(2):229-247. PubMed ID: 32339327
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States.
    Sutter RW; Prevots DR; Cochi SL
    Pediatr Clin North Am; 2000 Apr; 47(2):287-308. PubMed ID: 10761505
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
    Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polio vaccines: WHO position paper – March, 2016.
    Wkly Epidemiol Rec; 2016 Mar; 91(12):145-68. PubMed ID: 27039410
    [No Abstract]   [Full Text] [Related]  

  • 46. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016.
    Hampton LM; Farrell M; Ramirez-Gonzalez A; Menning L; Shendale S; Lewis I; Rubin J; Garon J; Harris J; Hyde T; Wassilak S; Patel M; Nandy R; Chang-Blanc D;
    MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(35):934-8. PubMed ID: 27606675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program.
    Domingues CM; de Fátima Pereira S; Cunha Marreiros AC; Menezes N; Flannery B
    J Infect Dis; 2014 Nov; 210 Suppl 1(0 1):S143-51. PubMed ID: 25316829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Introduction of inactivated poliovirus vaccine into oral poliovirus vaccine-using countries.
    Wkly Epidemiol Rec; 2003 Jul; 78(28):241-50. PubMed ID: 15571166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Supply and Demand Management Perspective on the Accelerated Global Introductions of Inactivated Poliovirus Vaccine in a Constrained Supply Market.
    Lewis I; Ottosen A; Rubin J; Blanc DC; Zipursky S; Wootton E
    J Infect Dis; 2017 Jul; 216(suppl_1):S33-S39. PubMed ID: 28838159
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Role of National Immunization Technical Advisory Groups (NITAGs) in the Introduction of Inactivated Polio Vaccine: Experience of the Indonesia and Uganda NITAGs.
    Ba-Nguz A; Adjagba A; Wisnu Hendrarto T; Sewankambo NK; Nalwadda C; Kisakye A
    J Infect Dis; 2017 Jul; 216(suppl_1):S109-S113. PubMed ID: 28838176
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The polio endgame.
    Minor P
    Hum Vaccin Immunother; 2014; 10(7):2106-8. PubMed ID: 25608050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide, 2013-2016.
    Immunization Systems Management Group of the Global Polio Eradication Initiative
    MMWR Morb Mortal Wkly Rep; 2015 Jul; 64(25):699-702. PubMed ID: 26135591
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polio eradication in the African Region on course despite public health emergencies.
    Okeibunor JC; Ota MC; Akanmori BD; Gumede N; Shaba K; Kouadio KI; Poy A; Mihigo R; Salla M; Moeti MR
    Vaccine; 2017 Mar; 35(9):1202-1206. PubMed ID: 26303876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The polio-eradication programme and issues of the end game.
    Minor PD
    J Gen Virol; 2012 Mar; 93(Pt 3):457-474. PubMed ID: 22128250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Succeeding in New Vaccine Introduction: Lessons Learned From the Introduction of Inactivated Poliovirus Vaccine in Cameroon, Kenya, and Nigeria.
    Scotney S; Snidal S; Saidu Y; Ojumu A; Ngatia A; Bagana M; Mutuku F; Sobngwi J; Efe-Aluta O; Roper J; LeTallec Y; Kang'ethe A
    J Infect Dis; 2017 Jul; 216(suppl_1):S130-S136. PubMed ID: 28838156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of Global Alliance for Vaccines and Immunization (GAVI) in Accelerating Inactivated Polio Vaccine Introduction.
    Thacker N; Thacker D; Pathak A
    Indian Pediatr; 2016 Aug; 53 Suppl 1():S57-S60. PubMed ID: 27771641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neutralizing anti-polio antibody titre in newborn babies in post-polio eradication period in Nigeria.
    Ughasoro MD; Nnakenyi I; Echendu N; Akpeh JO; Oji-Onuoha S; Anyaoha U; Mbanefo N; Ofodile K
    Vaccine; 2023 Nov; 41(46):6820-6823. PubMed ID: 37806806
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contribution of Global Polio Eradication Initiative-Funded Personnel to the Strengthening of Routine Immunization Programs in the 10 Focus Countries of the Polio Eradication and Endgame Strategic Plan.
    van den Ent MMVX; Swift RD; Anaokar S; Hegg LA; Eggers R; Cochi SL
    J Infect Dis; 2017 Jul; 216(suppl_1):S244-S249. PubMed ID: 28838165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating vaccine derived poliovirus and the polio eradication endgame.
    Davis R; Wright PF
    Pan Afr Med J; 2012; 12():109. PubMed ID: 23133709
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.